Core Viewpoint - The company, Kelun Pharmaceutical, announced on September 1 that its research institutes will focus on different therapeutic pipelines while complying with regulatory requirements [1] Group 1: Company Focus - Kelun Pharmaceutical's drug research institute will concentrate on innovative drug development in non-infusion formulations, primarily relying on its core marketing pipeline [1] - The focus areas for the drug research institute include anesthesia analgesia, central nervous system, and anti-infection [1] - The company has laid out more than ten varieties in its current pipeline [1]